Study on Human Vaccines for Oncogenic Viruses and Perspectives for Tumor Antigens Induced by Virus

Science Press Release Distribution Services

Study on Human Vaccines for Oncogenic Viruses and Perspectives for Tumor Antigens Induced by Virus

April 10, 2020 Medicine and Medical Science 0

The Variola major, the virus that causes the smallpox, lethal virus in the 30% of the cases, was eraticated in 1979 in the human species, thanks to a capillary vaccination on global scale. Recently the Word Health Organization (WHO) declared that India and Southeast Asia are polio-free, really a great achivement since the vaccine for polio, an infectious desease that can cause paralysis, was certificated safe and useful only 60 years ago. The vaccine for the virus, responsible for hepatitis B infection HBV, is able to prevent 50% of all liver cancers. Human Papilloma Virus (HPV) have been correlated with the cervical cancer (genotypes 16 and 18 particularly oncogenic in humans): the USA Food and Drug Administration (FDA) in 2006 released the first vaccine against HPV. Finally, the ability of the immune system to recognize a tumor-associated antigen enables the development of a vaccine approach for therapeutic application and represents a main target of this field of research. Long years of research were required for busting new systems to fight cancer. Research is going to obtain the complete sequence by proteomics approaches, in order to achieve adequate antigen preparations that might be used to generate assays for a specific anticancer vaccine.

Author(s) Details

Giulio Tarro
Beaumont Bonelli Foundation for Cancer Research, Naples, Italy and Committee on Biotechnologies and Virus Sphere, World Academy of Biomedical Technologies, UNESCO, Paris, France.

View Book :- http://bp.bookpi.org/index.php/bpi/catalog/book/161

 

Leave a Reply

Your email address will not be published. Required fields are marked *